FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.

First in a three-part series. This story was produced with support from the Pulitzer Center. In the past four springs, state employees in small planes and a helicopter have combed the skies of ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Elson Nash, an education and social impact leader, Senior Fellow at Blue Meridian Partners, and By All Means Senior Fellow at ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...

From chemical building blocks, scientists have created synthetic cells that have most of the hallmarks of life.

Missouri Master Naturalists, Chert Glades Chapter, will host an informational meeting for anyone interested in joining the fall Missouri Master Naturalists training class.

In 2025, first-time buyers had an average age of 40, according to the National Association of Realtors, an all-time high. And the share of first-time homebuyers on the market has decreased to a record ...

An enzyme-triggered tetrazine uncaging strategy for cell-selective bioorthogonal chemistry has now been developed. The method called TRACE (tetrazine release and activation by cellular enzymes) ...